AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Specialist healthcare property developer Assura announced on Monday the appointment of Steven Noble to the newly created position of chief investment officer (CIO), a strategic move aimed at supporting the company’s growth plans both in the short and long term. Noble will take on the role immediately and be responsible for implementing Assura’s investment strategy across various healthcare markets, with a particular focus on capital recycling initiatives.
Before joining Assura (LSE:AGR), Noble served as CIO at Atrato Group, where he oversaw significant transactions, including more than £2bn in property deals. His work played a key role in the development of Supermarket Income REIT (SUPR), helping it grow from its initial public offering to inclusion in the FTSE 250. Noble's background also includes a nine-year tenure at Lloyds, where he was involved in origination and risk management for commercial real estate, as well as time at KPMG, where he qualified as a chartered accountant.
Assura’s chief executive Jonathan Murphy commented on the appointment, highlighting Noble’s role as critical in advancing the company’s ambitious growth objectives. He noted the increasing challenges facing the UK healthcare system, which has resulted in rising demand for improved access to healthcare services nationwide. Assura, with its market position and expertise, is well-placed to respond to this demand by expanding infrastructure across a growing range of healthcare sectors.
Murphy further emphasized that Noble’s experience and skills will complement the strengths already present within the Executive Committee, helping the company meet the demands of the healthcare market and successfully execute its long-term strategy.
Assura continues to expand its footprint in the healthcare sector, focusing on providing essential infrastructure at a time when healthcare access is a pressing issue. The appointment of a chief investment officer marks a significant step in strengthening the company’s ability to navigate and grow in an increasingly complex healthcare landscape.
